GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedCann Industries Inc (OTCPK:NSRS) » Definitions » Debt-to-EBITDA

MedCann Industries (MedCann Industries) Debt-to-EBITDA : 0.00 (As of Apr. 2011)


View and export this data going back to 2011. Start your Free Trial

What is MedCann Industries Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

MedCann Industries's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Apr. 2011 was $0.00 Mil. MedCann Industries's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Apr. 2011 was $0.00 Mil. MedCann Industries's annualized EBITDA for the quarter that ended in Apr. 2011 was $-0.04 Mil. MedCann Industries's annualized Debt-to-EBITDA for the quarter that ended in Apr. 2011 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for MedCann Industries's Debt-to-EBITDA or its related term are showing as below:

NSRS's Debt-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.69
* Ranked among companies with meaningful Debt-to-EBITDA only.

MedCann Industries Debt-to-EBITDA Historical Data

The historical data trend for MedCann Industries's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedCann Industries Debt-to-EBITDA Chart

MedCann Industries Annual Data
Trend Apr11 Apr21
Debt-to-EBITDA
- -13.50

MedCann Industries Semi-Annual Data
Apr11 Apr21
Debt-to-EBITDA - -13.50

Competitive Comparison of MedCann Industries's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, MedCann Industries's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedCann Industries's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedCann Industries's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where MedCann Industries's Debt-to-EBITDA falls into.



MedCann Industries Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

MedCann Industries's Debt-to-EBITDA for the fiscal year that ended in Apr. 2011 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / -0.037
=0.00

MedCann Industries's annualized Debt-to-EBITDA for the quarter that ended in Apr. 2011 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / -0.037
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (Apr. 2011) EBITDA data.


MedCann Industries  (OTCPK:NSRS) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


MedCann Industries Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of MedCann Industries's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


MedCann Industries (MedCann Industries) Business Description

Traded in Other Exchanges
N/A
Address
10524 Independence Avenue, Chatsworth, CA, USA, 91311
MedCann Industries Inc is focused on the evaluation, acquisition, and development of products and businesses in the mineral resource, pharmaceutical, and medical technology industries. It creates and develops a Distribution, Research, and Manufacturing Facility. It intends to manufacture and assemble Medicine, Cosmetic, Health treatment products, and drinks. Its products include Cannabis Oil.

MedCann Industries (MedCann Industries) Headlines

No Headlines